Correlation and discordance of anti-mullerian hormone with follicle stimulating hormone in infertile women with premature ovarian insufficiency and diminished ovarian reserve

Shakeela Ishrat, Farzana Deeba, Shaheen Ara Anwary, Jesmine Banu


Background: The objective of the study was to explore the correlation and discordance of anti-mullerian hormone (AMH) and follicle stimulating hormone (FSH) in the selected population of premature ovarian insuffiency and diminished ovarian reserve.

Methods: This was a retrospective analysis of the data obtained from the women who presented to the Gynae Endocrine Clinic of the Infertility unit of the Department of Obstetrics & Gynaecology from 2015 to 2017. Discordance was defined as abnormal basal FSH (>10 IU/l) with assuring AMH (>1 ng/ml). Statistical analysis was done with SPSS version 23.

Results: There were 36 women with premature ovarian insufficiency and 35 women with diminished ovarian reserve. The correlations between basal FSH and AMH are not significant. AMH values are relatively higher in younger age groups. There are extreme high outliers in both POI and DOR groups, more in younger age group. The discordance between AMH and basal FSH was more in women categorized to have diminished ovarian reserve, compared to women with premature ovarian insufficiency.

Conclusions: Those women who are younger than 35 years and have high FSH combined with reassuring AMH should be counseled with care regarding the prognosis of their treatment.


Premature ovarian insufficiency, Diminished ovarian reserve, Follicle stimulating hormome, Anti-mullerian hormone

Full Text:



Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-37.

Rasool S, Shah D. Fertility with early reduction of ovarian reserve: the last straw that breaks the camel’s back. Fertil Res Pract. 2017;3:15.

Visser JA, Schipper I, Laven JCE, Themmen APN. Anti –Mullerian Hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331-841

Nelson SM, Yates WR, Fleming R. Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles—implications for individualization of therapy. Hum Reprod. 2007;22(9):2414-21.

Bala J, Agarwal Y, Seth S, Goyal V, Kumar P. Correlation between anti-mullerian hormone and follicle stimulation hormone in female infertility. Int J Heal Alli Sci. 2014;3(4):232-5.

Goksedef BP, Idis N, Gorgen H, Asma YR, Api M, Cetin A. The correlation of antral follicle count and anti-mullerian hormone. J Turkish –German Gynecol Assoc. 2010;11:212-5.

Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH) and anti- Mullerian hormone (AMH) in female infertility. Reproductive Biology and Endocrinology 2010;8:64.

Tehraninezhad ES, Mehrabi F, Taati R, Kalantar V, Aziminekoo E, Tarafdari A. Analysis of ovarian reserve markers (AMH,FSH,AFC) in different age strata in IVF/ICSI patients. Int J Reprod Biomed. 2016;14(8):501-6.

Panidis D, Katsikis I, Karkanaki A, Piouka A, Armeni AK, Georgopoulos NA. Serum anti- mullaerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulation hormone (FSH) levels. Medic Hypotheis. 2011;77:649-53.

Barbakadza L, Kristeshashvilli J, Khonelidze N, Tsagareishvilli G. The correlations of anti- mullerian hormone, follicle stimulating hormone and antral follicle count in different age groups of infertile women. Int J Fertil Steril. 2015;8(4):393-8.

Gleicher N, Weghofer A, Oktay K, Barad DH. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum Reprod. 2009;24(10):2395-400.

Singer T, Barad DH, Weghofer A, Gleicher N. Correlation of antimullerian hormone and baseline follicle stimulating hormone levels. Fertil Steril. 2009;91(6).

Iverson A, Younis A, Butler WJ, Roudebush WE. Inverse correspondence of AMH and FSH levels in women presenting for infertility treatment. J South Carol Acad Sci. 2011;9(2):1-4.

Wang S, Zhang Y, Mensah V, Huber WJ, Huang YT, Alvero R. Discordant anti-mullerian hormone (AMH), and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization(IVF): which one is better predictor of live birth? J Ovar Res. 2018;11:60.

Barad DH, Weghofer A, Geicher N. Comparing anti-Mullerian hormone (AMH) and follicle stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009;91(4):1553-5.

Geicher N, Kim A, Kushnir V, Weghofer A, Shohat-Tal A, Lazzaroni E et al. Clinical relevance of combined FSH and AMH Observations in infertile women. J Clin Endocrinol Metab. 2013;98(5):2146-55.

Laven JCE, Mulders AGMGJ, Visser JA, Themmen AP, De Jong FH, Fauser BCJM. Anti-mullerian hormone serum concentrations in normo-ovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89(1):318-23.

Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reproduct. 2004;19(9):2036-42.

Shukla S, Khuteta RP, Yadav R, Sharma K. Study of correlation of hormonal and sonographic markers of ovarian reserve in Indian women with primary infertility. Int J Res Med. 2016;5(2):147-9.